Amjad Ali Khan Selected Research

Oral Administration

1/2021

6-Gingerol, a Major Ingredient of Ginger Attenuates Diethylnitrosamine-Induced Liver Injury in Rats through the Modulation of Oxidative Stress and Anti-Inflammatory Activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Amjad Ali Khan Research Topics

Disease

20	Neoplasms (Cancer) 02/2024 - 04/2020
13	Inflammation (Inflammations) 02/2024 - 01/2018
2	Neoplasm Metastasis (Metastasis) 02/2024 - 03/2021
2	Body Weight (Weight, Body) 01/2023 - 02/2021
2	Diabetes Mellitus 01/2023 - 02/2021
2	Liver Diseases (Liver Disease) 01/2021 - 02/2019
1	Ovarian Neoplasms (Ovarian Cancer) 06/2023
1	Anemia 06/2023
1	Vomiting 06/2023
1	Alopecia (Baldness) 06/2023
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Hyperlipidemias (Hyperlipidemia) 01/2023
1	Diabetes Complications 01/2023
1	Hemolysis 01/2022
1	Bacterial Pneumonia 11/2021
1	Leukopenia 11/2021
1	Lung Injury 05/2021
1	Insulin Resistance 01/2021
1	Edema (Dropsy) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 04/2020
1	Hypertension (High Blood Pressure) 01/2018
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2018
1	Hyperglycemia 01/2018

Drug/Important Bio-Agent (IBA)

3	FlavonoidsIBA 02/2024 - 09/2022
3	AntioxidantsIBA 06/2023 - 03/2021
3	Blood Glucose (Blood Sugar)IBA 01/2023 - 01/2021
3	thymoquinoneIBA 11/2021 - 02/2019
3	LipidsIBA 05/2021 - 01/2018
2	QuercetinIBA 01/2023 - 03/2021
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2021
2	3-hydroxyflavoneIBA 01/2023 - 03/2021
2	Streptozocin (Streptozotocin)FDA Link 01/2023 - 02/2021
2	gingerolIBA 02/2021 - 01/2021
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2021
1	CateninsIBA 02/2024
1	LuteolinIBA 02/2024
1	MicroRNAs (MicroRNA)IBA 02/2024
1	mangiferinIBA 12/2023
1	formononetinIBA 06/2023
1	IsoflavonesIBA 06/2023
1	Phosphotransferases (Kinase)IBA 06/2023
1	Protein Kinases (Protein Kinase)IBA 06/2023
1	MitogensIBA 06/2023
1	Phosphatidylinositols (Phosphatidylinositol)IBA 06/2023
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 06/2023
1	myricetinIBA 06/2023
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 06/2023
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 06/2023
1	kaempferolIBA 05/2023
1	EndonucleasesIBA 04/2023
1	Insulin (Novolin)FDA Link 01/2023
1	Dinoprostone (PGE2)FDA Link 12/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2022
1	fisetinIBA 12/2022
1	Transcription Factors (Transcription Factor)IBA 12/2022
1	baicaleinIBA 11/2022
1	ApigeninIBA 09/2022
1	Hormones (Hormone)IBA 09/2022
1	ResveratrolIBA 04/2022
1	PolyphenolsIBA 04/2022
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2021
1	Benzo(a)pyreneIBA 05/2021
1	Therapeutic UsesIBA 05/2021
1	CarcinogensIBA 05/2021
1	Malondialdehyde (Propanedial)IBA 05/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2021
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2021
1	CollagenIBA 01/2021
1	Insulin-Like Growth Factor Binding ProteinsIBA 01/2021
1	CaspasesIBA 01/2021
1	CathepsinsIBA 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	Albumin-Bound Paclitaxel FDA Link 01/2021
1	liposomal doxorubicin (Doxil)FDA Link 01/2021
1	NK105IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 12/2020
1	Nucleotide AptamersIBA 12/2020
1	ProdrugsIBA 11/2020
1	TeaIBA 07/2020
1	Catechin (Z 7300)IBA 07/2020
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 07/2020
1	Liposomes (Liposome)IBA 04/2020
1	Drug CarriersIBA 04/2020
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Advanced Glycation End ProductsIBA 01/2018
1	Nitric Oxide Synthase (NO Synthase)IBA 12/2014
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 12/2014

Therapy/Procedure

12	Therapeutics 02/2024 - 07/2020
5	Drug Therapy (Chemotherapy) 12/2023 - 04/2022
5	Radiotherapy 12/2023 - 04/2022
1	Immunotherapy 01/2023
1	Cell- and Tissue-Based Therapy (Cell Therapy) 12/2022
1	Complementary Therapies (Alternative Medicine) 03/2021
1	Oral Administration 01/2021
1	Precision Medicine 01/2021